These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18086416)

  • 1. Gene therapy to induce cellular resistance to HIV-1 infection: lessons from clinical trials.
    Giacca M
    Adv Pharmacol; 2008; 56():297-325. PubMed ID: 18086416
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioneering HIV treatment would use interference and gene therapy.
    Check E
    Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193002
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical protocols using gene therapy for HIV infection.
    Tecnologica; 1995 May; ():1, 3-6. PubMed ID: 10168289
    [No Abstract]   [Full Text] [Related]  

  • 4. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 5. Mapping the future of HIV vaccines.
    Nabel GJ
    Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457
    [No Abstract]   [Full Text] [Related]  

  • 6. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A transcription factor acts as a HIV-1 accomplice to destroy the cellular defences].
    Marquet R; Guerrero S; Bernacchi S; Pernot S; Batisse J; Paillart JC
    Med Sci (Paris); 2012 Apr; 28(4):356-8. PubMed ID: 22549857
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy for HIV infection: what does it need to make it work?
    von Laer D; Hasselmann S; Hasselmann K
    J Gene Med; 2006 Jun; 8(6):658-67. PubMed ID: 16598816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building an HIV-proof immune system.
    Cohen J
    Science; 2007 Aug; 317(5838):612-4. PubMed ID: 17673648
    [No Abstract]   [Full Text] [Related]  

  • 10. All clear for HIV-targeting ribozyme in phase II.
    Brower V; Chahine K; Dorey E; Dove A; Francisco M; Hodgson J; Michael A; Marshall A
    Nat Biotechnol; 1998 Feb; 16(2):123. PubMed ID: 9487501
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 gene therapy: promise for the future.
    Dornburg R; Pomerantz RJ
    Adv Pharmacol; 2000; 49():229-61. PubMed ID: 11013766
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection.
    Liao CH; Kuang YQ; Liu HL; Zheng YT; Su B
    AIDS; 2007 Dec; 21 Suppl 8():S19-26. PubMed ID: 18172386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathology and gene therapy of HIV infection].
    Matsushita S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):651-3. PubMed ID: 9081734
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV pathogenesis: 25 years of progress and persistent challenges.
    Levy JA
    AIDS; 2009 Jan; 23(2):147-60. PubMed ID: 19098484
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
    Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
    J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral gene therapy.
    von Laer D; Baum C; Protzer U
    Handb Exp Pharmacol; 2009; (189):265-97. PubMed ID: 19048204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing HIV-1 In Vivo.
    Kirchhoff F
    Cell; 2008 Aug; 134(4):566-8. PubMed ID: 18724929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.